Dearborn Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,972
| Closed | -$342K | – | 270 |
|
|
2024
Q4 | $342K | Buy |
3,972
+400
| +11% | +$34.4K | 0.01% | 201 |
|
|
2024
Q3 | $425K | Hold |
3,572
| – | – | 0.02% | 190 |
|
|
2024
Q2 | $510K | Buy |
3,572
+200
| +6% | +$28.5K | 0.02% | 166 |
|
|
2024
Q1 | $433K | Hold |
3,372
| – | – | 0.02% | 177 |
|
|
2023
Q4 | $349K | Buy |
3,372
+500
| +17% | +$51.7K | 0.01% | 189 |
|
|
2023
Q3 | $261K | Hold |
2,872
| – | – | 0.01% | 204 |
|
|
2023
Q2 | $232K | Hold |
2,872
| – | – | 0.01% | 216 |
|
|
2023
Q1 | $229K | Buy |
+2,872
| New | +$229K | 0.01% | 221 |
|
|
2022
Q3 | – | Sell |
-3,596
| Closed | -$200K | – | 263 |
|
|
2022
Q2 | $200K | Buy |
+3,596
| New | +$200K | 0.01% | 249 |
|